RNA Sequencing and Bioinformatics Analysis to Reveal Potential Biomarkers in Patients with Combined Allergic Rhinitis and Asthma Syndrome
Zheng-Dao Mao,Zhi-Guang Liu,Yan Qian,Yu-Jia Shi,Lian-Zheng Zhou,Qian Zhang,Chun-Jian Qi
DOI: https://doi.org/10.2147/jir.s438758
IF: 4.5
2023-12-20
Journal of Inflammation Research
Abstract:Zheng-Dao Mao, 1, &ast Zhi-Guang Liu, 1, &ast Yan Qian, 1 Yu-Jia Shi, 1 Lian-Zheng Zhou, 1 Qian Zhang, 1 Chun-Jian Qi 2 1 Department of Respiratory and Critical Care Medicine, Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou, People's Republic of China; 2 Central Laboratory, Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou, People's Republic of China &astThese authors contributed equally to this work Correspondence: Chun-Jian Qi, Laboratory of Oncology, Changzhou Second People's Hospital, Changzhou Medical Center, Nanjing Medical University, Changzhou, 213003, People's Republic of China, Tel +86-519-81087391, Email Qian Zhang, Department of Respiratory and Critical Care Medicine, Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, No. 29 Xinlong Road, Changzhou, 213003, People's Republic of China, Tel +86-519-81087391, Email Introduction: Combined allergic rhinitis and asthma syndrome (CARAS) is a concurrent clinical or subclinical allergic symptom of diseases of the upper and lower respiratory tract. This study is the first to explore the expression profiles of mRNA, lncRNA, and circRNA in CARAS using RNA sequencing, which may provide insight into the mechanisms underlying CARAS. Material and Methods: Whole blood samples from nine participants (three CARAS patients, three AR patients, and three normal control participants) were subjected to perform RNA sequencing, followed by identification of differentially expressed lncRNAs (DElncRNAs), circRNAs (DEcircRNAs) and mRNAs (DEmRNAs). Then, lncRNA/circRNA-mRNA regulatory pairs were constructed, followed by functional analysis, immune infiltration analysis, drug prediction, and expression validation with RT-qPCR and ELISA. Results: The results showed that 61 DEmRNAs, 23 DElncRNAs and 3 DEcircRNAs may be related to the occurrence and development of CARAS. KRT8 may be implicated in the development of AR into CARAS. Three immunity-related mRNAs (IDO1, CYSLTR2, and TEC) and two hypoxia-related mRNAs (TKTL1 and VLDLR) were associated with the occurrence and development of CARAS. TEC may be considered a drug target for Dasatinib in treating CARAS. Several lncRNA/circRNA-mRNA regulatory pairs were identified in CARAS, including LINC00452/MIR4280HG/hsa_circ_0007272/hsa_circ_0070934-CLC, HEATR6-DT/LINC00639/LINC01783/hsa_circ_0008903-TEC, RP11-71L14.3-IDO1/SMPD3, RP11-178F10.2-IDO1/HRH4, and hsa_circ_0008903-CYSLTR2, which may indicate potential regulatory effects of lncRNAs/circRNAs in CARAS. Dysregulated levels of immune cell infiltration may be closely related to CARAS. Conclusion: The regulating effect of lncRNA/circRNA-immunity/hypoxia-related mRNA regulatory pairs may be involved in the occurrence and development of CARAS. Keywords: combined allergic rhinitis and asthma syndrome, lncRNA, circRNA, immunity, hypoxia Combined allergic rhinitis and asthma syndrome (CARAS), a new terminology introduced by the World Allergy Organization (WAO) in 2004, is an allergic reaction that occurs in the respiratory tract, including upper respiratory tract allergy (allergic rhinitis, AR) and lower respiratory tract allergy (asthma, AS). 1,2 The incidence of AS in patients with AR is reported to be higher than that in normal populations. 3 It has been proved that AR and AS are both manifestations of a single inflammatory process. 4 AR is an infectious inflammatory disease of the nasal mucosa (mainly mediated by IgE). 5 AS is a chronic inflammatory disease of the airway, and the occurrence and development of AS involves various cells and cellular components. 6–8 The continuity of the nasal cavity and bronchus in anatomical structure and physiological function determines the relationship between AR and AS. In addition, rhinosinusitis, a disease similar to AR, often occurs in conjunction with AS and has been associated with severity of AS. 9 In the vast majority of cases, the immune pathogenesis of the inflammatory process underlying AS and chronic rhinosinusitis is characterized by type 2 inflammation, which involves the process of cellular infiltration. 10 At present, researchers working on CARAS are focusing on mechanisms underlying local pathogenesis, such as the synthesis mechanism of immunoglobulin E (IgE) in the local respiratory tract and the differentiation mechanism of selective T cells. 5,11 These local mechanisms determine whether the inflammatory response to inhaling allergens is expressed in the upper or lower respiratory tract. In addition, the pathogenesis of CARAS is associated -Abstract Truncated-
immunology